Skip to main content

Table 1 Baseline clinicopathological characteristics of patients with colorectal cancer

From: A novel inflammation-related prognostic biomarker for predicting the disease-free survival of patients with colorectal cancer

Variables

No. of patients (%)

No. of outcome (%)

Gender

 Female

243 (37.62)

36 (37.89)

 Male

403 (62.38)

59 (62.11)

Age

 ≥60

379 (58.67)

53 (55.79)

 <60

267 (41.33)

42 (42.21)

Adjuvant therapy

 No

248 (38.39)

28 (29.47)

 Chemotherapy

376 (58.20)

63 (66.32)

 Othera

22 (3.41)

4 (4.21)

BMI

 ≥24

198 (30.65)

28 (29.47)

 <18.5

40 (6.19)

5 (5.26)

 18.5–23.9

408 (63.16)

62 (65.27)

Smoking

 No

602 (93.19)

83 (87.37)

 Yes

44 (6.81)

12 (12.63)

Drinking

 No

462 (71.5)

68 (71.58)

 Yes

184 (28.5)

27 (28.42)

Comorbidity

 No

310 (47.99)

46 (48.42)

 Yes

336 (52.01)

49 (51.58)

Family history of cancer

 No

515 (79.72)

75 (78.95)

 Yes

131 (20.28)

20 (21.05)

Tumor stage

 I

120 (18.57)

8 (8.42)

 II

233 (36.07)

19 (20.00)

 III

248 (38.39)

39 (41.05)

 IV

45 (6.97)

29 (30.53)

Specimen type

 Raised type

236 (36.53)

26 (27.37)

 Ulcer type

362 (56.04)

52 (54.74)

 Otherb

48 (7.43)

17 (17.89)

Tumor differentiation

 Well

19 (2.94)

3 (3.16)

 Moderate

555 (85.91)

73 (76.84)

 Poor

33 (5.11)

12 (12.63)

 Undifferentiated

39 (6.04)

7 (7.37)

Histological classification

 Adenocarcinoma

565 (87.46)

82 (86.32)

 Mucinous carcinoma and otherc

81 (12.54)

13 (13.68)

Tumor site

 Colon

337 (52.17)

58 (61.05)

 Rectum

281 (43.50)

33 (34.74)

 Otherd

28 (4.33)

4 (4.21)

Lymph node metastasis

 No

386 (59.75)

38 (40.00)

 Yes

260 (40.25)

57 (60.00)

Tumor size

 ≥3cm

460 (71.21)

75 (78.95)

 <3cm

186 (28.79)

20 (21.05)

  1. Abbreviation: BMI body mass index
  2. aIncluded radiotherapy or chemoradiotherapy
  3. bIncluded superficial type, undifferentiated type, and ulcer infiltrating type
  4. cIncluded undifferentiated carcinoma
  5. dIncluded cecum, junction of the rectum and sigmoid colon, and multi-site tumors